Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > DM-1


Brief Information

Name:Myotonin-protein kinase
Target Synonym:Myotonin-Protein Kinase,Dystrophia Myotonica 1,DMPK,MT-PK,DMK,Myotonic dystrophy protein kinase,DM1 protein kinase,DM1PK,Dystrophia Myotonica Protein Kinase,DM1,DM,DM Protein Kinase,Thymopoietin Homolog,MDPK,Myotonic Dystrophy Associated Protein Kinase,Dystrophia Myotonica 1 (Includes Dystrophia Myotonia Protein Kinase),DM-kinase,Myotonin Protein Kinase A
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data


Immobilized Trastuzumab-DM1 (T-DM1) at 2 μg/mL (100 μL/well) can bind HRP conjugated Monoclonal Anti-DM-1&DM-4 Antibody,Mouse IgG1 (Cat. No. DM1-PLY73) with a linear range of 0.24-15.63 ng/mL (QC tested).

DM-1 MALS images

The purity of Biotinylated Monoclonal Anti-DM-1&DM-4 Antibody, Mouse IgG1 (Cat. No. DM1-BLY73) is more than 90% and the molecular weight of this protein is around 140-160 kDa verified by SEC-MALS.

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Dyne-101 Dyne101 Phase 2 Clinical Dyne Therapeutics Inc Myotonic Dystrophy; Muscular Atrophy Details
ARO-DM1 ARO-DM1 Phase 2 Clinical Arrowhead Pharmaceuticals Inc Myotonic Dystrophy Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message